Viewing Study NCT06177067


Ignite Creation Date: 2025-12-25 @ 12:28 AM
Ignite Modification Date: 2025-12-25 @ 10:35 PM
Study NCT ID: NCT06177067
Status: RECRUITING
Last Update Posted: 2025-12-17
First Post: 2023-12-11
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia
Sponsor: St. Jude Children's Research Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module